Acquired BRAF V600E Mutation Mediated Resistance to Osimertinib and Responded to Osimertinib, Dabrafenib, and Trametinib Combination Therapy.
作者信息
Huang Yihua, Gan Jiadi, Guo Kunbin, Deng Yangyang, Fang Wenfeng
机构信息
Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, China.
出版信息
J Thorac Oncol. 2019 Oct;14(10):e236-e237. doi: 10.1016/j.jtho.2019.05.040.
PMID:31558239
Abstract
摘要
Zotero 插件